Serum IGF-II and Cancer: Can IGF II Levels be Used to Monitor and Screen Patients Specifically for Cervical Cancer

Clinical trial NCT01371695 · UNKNOWN

Trial details

NCT number: NCT01371695
Sponsor: Onconix, Inc
Status: UNKNOWN
Study type: OBSERVATIONAL

Cervical Cancer Cervical Intraepithelial Neoplasia II Cervical Intraepithelial Neoplasia III

Start date: 2011-05-01
Primary completion: 2011-09-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.